The trial aims to assess the tolerability, safety, efficacy, functional outcomes, and dystrophin expression in affected patients.
The FDA has cleared the company's investigational new drug application seeking to begin the Phase I/II FUNCTION-DMD trial.
A new resource from the Gene Ontology Consortium, a comprehensive encyclopedia of the known functions of all protein-coding human genes, has been completed and released on a new website. For the first ...